Publication:
Neuroprotective effects of the new Na channel blocker rs100642 in global ischemic brain injury

Simple item page
dc.contributor.authorKAMIŞLI, SUAT
dc.contributor.authorBasaran, Cenk
dc.contributor.authorBATÇIOĞLU, KADİR
dc.contributor.authorÖZTANIR, MUSTAFA NAMIK
dc.contributor.authorGÜL, MEHMET
dc.contributor.authorSATILMIŞ, BASRİ
dc.contributor.authorUYUMLU, AYŞE BURÇİN
dc.contributor.authorKAYHAN, BAŞAK
dc.contributor.authorGenc, Metin
dc.contributor.institutionauthorÖZTANIR, MUSTAFA NAMIK
dc.date.accessioned2021-01-27T20:59:11Z
dc.date.available2021-01-27T20:59:11Z
dc.date.issued2019-03-01T00:00:00Z
dc.description.abstractIntroduction: RS100642, a mexiletine analogue, is a novel sodium channel blocker with neuroprotective and antioxidant activities. The protectivity of RS100642, which has been shown against focal cerebral ischemia, was investigated in global cerebral ischemia in this study.
dc.identifier.citationKAMIŞLI S., Basaran C., BATÇIOĞLU K., ÖZTANIR M. N. , GÜL M., SATILMIŞ B., UYUMLU A. B. , KAYHAN B., Genc M., -Neuroprotective effects of the new Na channel blocker rs100642 in global ischemic brain injury-, ARCHIVES OF MEDICAL SCIENCE, cilt.15, ss.467-474, 2019
dc.identifier.doi10.5114/aoms.2017.72550
dc.identifier.scopus85062735430
dc.identifier.urihttp://hdl.handle.net/20.500.12645/28178
dc.identifier.wosWOS:000460168400021
dc.titleNeuroprotective effects of the new Na channel blocker rs100642 in global ischemic brain injury
dc.typeArticle
dspace.entity.typePublication
local.avesis.id43e8405a-f08a-4457-a73e-e209ec186ba3
local.publication.isinternational1
relation.isAuthorOfPublicationae4f7327-851c-4ef2-94a7-789ed77869a8
relation.isAuthorOfPublication.latestForDiscoveryae4f7327-851c-4ef2-94a7-789ed77869a8

Files

Collections

Silinecekler